Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
US GoldMining
USGO
$119M
| $91K | ﹤0.01% |
+10,571
| New | +$106K |
|
3302
Traws Pharma
TRAW
$9.14M
| $89.3K | ﹤0.01% |
+10,052
| New | +$56K |
|
3303
SurgePays
SURG
$6.2M
| $87.9K | ﹤0.01% |
49,400
+15,000
| +44% | +$26.4K |
|
3304
Fathom Holdings
FTHM
$24.5M
| $87.7K | ﹤0.01% |
57,300
+2,600
| +5% | +$5.66K |
|
|
GURE
3305
Gulf Resources
GURE
$5.48M
| $86.9K | ﹤0.01% |
15,317
-152
| -1% | -$1.04K |
|
|
QNRX
3306
Quoin Pharmaceuticals
QNRX
$12.2M
| $86.6K | ﹤0.01% |
3,803
+2,698
| +244% | +$61.9K |
|
3307
Relmada Therapeutics
RLMD
$507M
| $85.5K | ﹤0.01% |
164,513
+138,625
| +535% | +$338K |
|
3308
System1
SST
$17.8M
| $85.3K | ﹤0.01% |
9,500
+1,070
| +13% | +$10.8K |
|
|
OPTN
3309
DELISTED
OptiNose
OPTN
| $85.2K | ﹤0.01% |
12,748
-2,385
| -16% | -$21K |
|
3310
ClearSign Technologies
CLIR
$28.9M
| $84.2K | ﹤0.01% |
+5,850
| New | +$57.8K |
|
3311
Werewolf Therapeutics
HOWL
$18.8M
| $84.2K | ﹤0.01% |
56,900
-95,300
| -63% | -$194K |
|
|
KNDI
3312
Kandi Technologies Group
KNDI
$64.4M
| $83.9K | ﹤0.01% |
69,934
+22,934
| +49% | +$29.9K |
|
3313
RenovoRx
RNXT
$56.8M
| $83.7K | ﹤0.01% |
+64,900
| New | +$73.9K |
|
|
YARW
3314
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
| $83.6K | ﹤0.01% |
499
-1,234
| -71% | -$161K |
|
|
YI
3315
111 Inc
YI
$33.4M
| $83.1K | ﹤0.01% |
13,345
-80
| -0.6% | -$624 |
|
3316
SKYX Platforms
SKYX
$148M
| $82.2K | ﹤0.01% |
+70,850
| New | +$81K |
|
|
UHG
3317
DELISTED
United Homes Group
UHG
| $81.4K | ﹤0.01% |
19,247
+555
| +3% | +$3.07K |
|
3318
Cytosorbents Corp
CTSO
$22.8M
| $80.1K | ﹤0.01% |
88,020
+8,400
| +11% | +$8.24K |
|
|
FRSX
3319
Foresight Autonomous Holdings
FRSX
$3.93M
| $78.4K | ﹤0.01% |
2,522
+572
| +29% | +$9.35K |
|
3320
PharmaCyte Biotech
PMCB
$5.9M
| $77.4K | ﹤0.01% |
49,300
-400
| -0.8% | -$690 |
|
|
SOHO
3321
DELISTED
Sotherly Hotels
SOHO
| $77.2K | ﹤0.01% |
82,914
-19,000
| -19% | -$21.1K |
|
|
FTH
3322
Faeth Therapeutics
FTH
$738M
| $76.8K | ﹤0.01% |
7,840
-2,939
| -27% | -$29.5K |
|
|
INCR
3323
Intercure
INCR
$54.9M
| $76.8K | ﹤0.01% |
48,300
-500
| -1% | -$787 |
|
3324
SiNtx Technologies
SINT
$10.9M
| $76.7K | ﹤0.01% |
+21,900
| New | +$73.5K |
|
|
HERE
3325
Here Group Ltd
HERE
$101M
| $76.2K | ﹤0.01% |
35,300
+900
| +3% | +$2.66K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.